These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis. Zhao Y, Traboulsee A, Petkau AJ, Li D. Neurology; 2008 Mar 25; 70(13 Pt 2):1092-7. PubMed ID: 18003938 [Abstract] [Full Text] [Related]
16. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Sormani MP, Rovaris M, Comi G, Filippi M. Neurology; 2009 Nov 10; 73(19):1538-42. PubMed ID: 19794123 [Abstract] [Full Text] [Related]
19. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Stewart N, Simpson S, van der Mei I, Ponsonby AL, Blizzard L, Dwyer T, Pittas F, Eyles D, Ko P, Taylor BV. Neurology; 2012 Jul 17; 79(3):254-60. PubMed ID: 22700816 [Abstract] [Full Text] [Related]